PULMONARY OEDEMA: Fluid Accumulation in the Alveoli
Pulmonary oedema occurs when fluid accumulates within the interstitial and alveolar spaces of the lungs, disrupting normal gas exchange and reducing lung compliance. The presence of fluid within the alveoli replaces air, limiting oxygen diffusion and increasing the work of breathing. Although pulmonary oedema presents clinically with breathlessness and hypoxaemia, the underlying mechanisms differ depending on whether the cause is cardiogenic or non-cardiogenic.
Understanding the pathophysiology of pulmonary oedema is essential for distinguishing cardiac causes, such as heart failure, from inflammatory causes, such as acute respiratory distress syndrome (ARDS). While both result in alveolar flooding, the forces driving fluid movement and the composition of the oedema fluid are fundamentally different.
What You Need to Know
Pulmonary oedema occurs when fluid accumulates within the alveoli, disrupting normal gas exchange. Under normal conditions, pulmonary capillary pressures and oncotic forces are balanced so that only a small amount of fluid leaves the capillaries. This fluid is cleared efficiently by the lymphatic system, keeping the alveoli dry and optimised for oxygen diffusion. When this balance is disturbed, fluid moves into the interstitium faster than it can be removed and eventually floods the alveoli.
Two broad mechanisms lead to pulmonary oedema. In cardiogenic pulmonary oedema, elevated hydrostatic pressure within the pulmonary capillaries forces fluid outward, most commonly due to left-sided heart failure or acute cardiac dysfunction. In non-cardiogenic pulmonary oedema, capillary permeability is increased due to direct or indirect lung injury, allowing protein-rich fluid to leak into the alveoli even when pressures are normal. Although the initiating mechanisms differ, both processes result in alveolar flooding and impaired oxygen transfer.
The key physiological consequences of pulmonary oedema include:
Alveolar flooding, which replaces air with fluid and reduces the surface area available for gas exchange
Impaired oxygen diffusion, as oxygen must cross a fluid-filled barrier to reach capillary blood
Reduced lung compliance, making the lungs stiffer and increasing the work of breathing
As fluid accumulates, ventilation–perfusion mismatch develops because perfusion continues through poorly ventilated alveoli. Hypoxaemia may progress rapidly, particularly when alveolar flooding is widespread. Lung compliance falls as fluid-filled alveoli collapse, forcing patients to breathe more rapidly and shallowly to maintain ventilation. These changes explain the acute breathlessness, hypoxia, and respiratory distress that characterise pulmonary oedema, regardless of whether the underlying cause is cardiogenic or non-cardiogenic.
Beyond the Basics
Cardiogenic Pulmonary Oedema: Raised Hydrostatic Pressure
Cardiogenic pulmonary oedema develops when elevated pressures on the left side of the heart are transmitted backward into the pulmonary circulation. The most common cause is left-sided heart failure, where impaired left ventricular ejection leads to rising left atrial and pulmonary venous pressures. As pulmonary capillary hydrostatic pressure increases, the balance of Starling forces shifts, driving fluid out of the capillaries into the interstitial space and, once lymphatic clearance is overwhelmed, into the alveoli.
Importantly, the alveolar–capillary membrane remains structurally intact in cardiogenic oedema. The leaked fluid is therefore relatively low in protein and reflects pressure-driven filtration rather than inflammatory injury. As alveoli fill with fluid, lung compliance falls and greater effort is required to inflate the lungs. Perfusion continues through these fluid-filled alveoli, producing ventilation–perfusion mismatch and hypoxaemia. As left ventricular dysfunction worsens, pulmonary pressures rise further, accelerating alveolar flooding and respiratory compromise.
Non-Cardiogenic Pulmonary Oedema: Increased Capillary Permeability
Non-cardiogenic pulmonary oedema arises from direct injury to the alveolar–capillary membrane rather than elevated hydrostatic pressure. Conditions such as acute respiratory distress syndrome, severe sepsis, inhalational injury, and acute lung inflammation damage endothelial and epithelial tight junctions. This loss of barrier integrity allows protein-rich fluid to leak freely into the interstitium and alveoli, even when pulmonary capillary pressures are normal.
The presence of protein-rich oedema fluid has important physiological consequences. Surfactant becomes diluted and inactivated, increasing surface tension within alveoli and promoting collapse at end-expiration. Collapsed and fluid-filled alveoli are poorly ventilated yet remain perfused, creating intrapulmonary shunt. Because blood passes through these regions without effective gas exchange, hypoxaemia is often severe and responds poorly to supplemental oxygen. Pulmonary capillary wedge pressure is typically normal, reflecting the absence of primary left-sided cardiac failure.
Effects on Lung Mechanics and Gas Exchange
Regardless of cause, pulmonary oedema reduces the surface area available for gas exchange. Oxygen diffusion becomes inefficient because oxygen must traverse fluid-filled alveoli to reach capillary blood. Carbon dioxide elimination is usually preserved early because CO₂ diffuses more readily, but as oedema progresses and alveolar ventilation falls, hypercapnia may develop.
Fluid accumulation also makes the lungs stiff and less compliant. Higher inspiratory pressures are required to achieve adequate tidal volumes, increasing the work of breathing. Patients compensate with tachypnoea and shallow breaths, a pattern that limits alveolar ventilation and hastens respiratory muscle fatigue.
Progression to Respiratory Failure
If pulmonary oedema is severe or inadequately treated, gas exchange deteriorates further and respiratory muscles fatigue. In cardiogenic oedema, ongoing left ventricular failure perpetuates rising pulmonary pressures and continued fluid transudation. In non-cardiogenic oedema, persistent inflammation and epithelial injury sustain alveolar flooding and collapse.
Both pathways commonly lead to Type 1 respiratory failure due to refractory hypoxaemia. In advanced stages, mixed or Type 2 respiratory failure may develop as ventilatory effort can no longer be sustained. At this point, respiratory support is often required to stabilise gas exchange and reduce the work of breathing.
Clinical Connections
Pulmonary oedema most often presents with sudden onset dyspnoea, tachypnoea, hypoxaemia, and widespread crackles on auscultation as fluid accumulates within the alveoli. Pink, frothy sputum reflects severe alveolar flooding and mixing of air, fluid, and surfactant. Patients may appear acutely distressed, with increased work of breathing and rapid deterioration if gas exchange worsens. In cardiogenic pulmonary oedema, symptoms frequently evolve in the context of known or decompensating left-sided heart disease, whereas non-cardiogenic oedema typically develops alongside systemic illness, severe infection, trauma, or direct lung injury.
Several clinical features help differentiate the underlying mechanism and guide early management:
Evidence of elevated filling pressures, such as orthopnoea, peripheral oedema, or acute weight gain, suggesting a cardiogenic process
Normal cardiac findings with severe hypoxaemia, pointing toward increased capillary permeability rather than pressure overload
Poor oxygen response despite high-flow oxygen, raising concern for shunt physiology seen in non-cardiogenic oedema
Chest imaging usually demonstrates bilateral infiltrates, but the pattern provides important clues. Cardiogenic pulmonary oedema often shows perihilar or dependent opacities and may be accompanied by cardiomegaly or pleural effusions, reflecting raised hydrostatic pressure. Non-cardiogenic oedema more commonly produces diffuse, patchy infiltrates with normal heart size, consistent with widespread alveolar–capillary injury. Correctly identifying the dominant mechanism is essential, as pressure-driven oedema responds to preload and afterload reduction, while permeability-driven oedema requires treatment of the underlying inflammatory or injurious process alongside supportive respiratory care.
Concept Check
How does increased hydrostatic pressure lead to alveolar flooding in cardiogenic pulmonary oedema?
Why is the oedema fluid protein-rich in non-cardiogenic pulmonary oedema?
How does pulmonary oedema impair oxygen diffusion?
Why is hypoxaemia often more severe in non-cardiogenic pulmonary oedema?
How can pulmonary oedema progress to respiratory failure?